Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shobi Mathew

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|March 3, 2022
Hyperglycinuria: diagnosis in middle ageHithem Fargaly, Shobi Mathew, Noreen F Rossi
Resuscitation|February 12, 2023
Treatment and outcome variation in out-of-hospital cardiac arrest among four urban hospitals in DetroitShobi Mathew, Nicholas Harrison, Sukhwindar Ajimal, et al.
The American Journal of Emergency Medicine|March 19, 2021
Effects of the COVID-19 pandemic on out-of-hospital cardiac arrest care in DetroitShobi Mathew, Nicholas Harrison, Adam D Chalek, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophyCesar A Romero, Shobi Mathew, Benjamin Wasinski, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|March 3, 2022
Hyperglycinuria: diagnosis in middle ageHithem Fargaly, Shobi Mathew, Noreen F Rossi
Resuscitation|February 12, 2023
Treatment and outcome variation in out-of-hospital cardiac arrest among four urban hospitals in DetroitShobi Mathew, Nicholas Harrison, Sukhwindar Ajimal, et al.
The American Journal of Emergency Medicine|March 19, 2021
Effects of the COVID-19 pandemic on out-of-hospital cardiac arrest care in DetroitShobi Mathew, Nicholas Harrison, Adam D Chalek, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophyCesar A Romero, Shobi Mathew, Benjamin Wasinski, et al.
Pageof 1